Skip to main content

ASAHI SONGWON COLORS LTD (138)


ASAHI SONGWON COLORS LTD (532853& NSE as “ASAHISONG”) (138)

On 18th November 2013, we had recommended this stock at Rs.69, after our recommendation it zoomed to Rs.192 levels on 2nd November 2014. After demerger again we are recommending this stock.
Asahi Songwon Colors Ltd.   is in the business of manufacturing pigments.  Pigments are basically colourants, adding colour to everything  around us, namely ink, paints, plastics, textiles, rubber etc. ASCL was promoted by Mrs. Paru M. Jaykrishna, having rich business experience in the field of manufacturing Pigments & Chemicals and Travel Industry. Mrs. Paru M. Jaykrishna started Pigment Manufacturing activities in 1994 by setting up plant for manufacturing Pigment Green – 7 at Kadi, Mehsana in Gujarat.The company also exports its products to the United States, Europe, and the Asian countries.
Company has an equity base of Rs.12.27crore that is supported by reserves of around Rs.105.71crore which is 8.61 times higher than the equity and has a share book value of Rs.120.24 and price: book value ratio is just 1.15, which is highly impressive. The promoters hold 62.28% while the investing public holds 37.72% stake in the company. 
Financial Performance

Q1FY16
Q1FY15
FY15
Sales
58.02
81.20
240.47
Profit Before Tax
7.64
6.60
25.96
Tax
2.60
2.38
8.65
Profit After Tax
5.04
4.22
17.70
EPS
4.11
3.43
14.42
For Q1FY16, sales have decrease 40% to Rs.58.02crore (because of demerger of the pigment green division of Asahi Songwon to AksharChem (India) Ltd. The swap ratio was five equity shares of AksharChem (India) of ₹10 each fully paid-up for every 26 equity shares of Asahi Songwon Colors). Despite of lower topline & rise in income tax, PAT has jumped by 19.43% to Rs.5.04crore. Q1FY16 EPS stood at Rs.4.11. The scrip is trading at P/E multiple of just 9.3.
Company is regularly paying dividend to its shareholders. It has paid 35% dividend for FY14 & declares 35% dividend for FY15. Stock is still available with dividend right. 
Stock is looking explosive for investment. Investors can buy this stock with a stop loss of Rs.125. On the upper side, it will zoom to Rs.165--170 levels in the medium term while stock may zoom up to its all-time high rate of Rs.192 in the next 8--10 months.



Comments

Post a Comment

Popular posts from this blog

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News*   *TCI FINANCE LTD (501242 & NSE) (31)*   Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc.   The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL   The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services.   *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...
1 comment
Read more

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige...
1 comment
Read more

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals  reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such...
Post a Comment
Read more